Kewaunee Scientific stock gained 0.74 percent as backlog rose

Published on 10/04/2026 at 20:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Kewaunee Scientific stock gained 0.74 percent to USD 34.16 on October 2, 2026. Fiscal Q1 sales fell 6.7 percent, while backlog rose to USD 169.0 million.

KEQU, US4928541048, Illustration mit AI erstellt.

Kewaunee Scientific stock (ISIN US4928541048) gained 0.74 percent to USD 34.16 on Nasdaq on October 2, 2026, leaving the price 26.65 percent below its 52-week high of USD 46.57. The latest operating picture is mixed: fiscal Q1 2027 sales declined 6.7 percent to USD 66.32 million, while backlog increased to USD 169.0 million.

Sales fell as backlog improved

According to PR Newswire on September 9, 2026, Kewaunee reported fiscal Q1 2027 sales of USD 66.32 million for the three months ended July 31, 2026, compared with USD 71.104 million a year earlier. Pre-tax earnings dropped 34.7 percent to USD 2.56 million, and diluted EPS declined to USD 0.58 from USD 1.04.

The order book offered a counterpoint to the weaker income statement. Backlog stood at USD 169.0 million on July 31, 2026, up from USD 165.9 million on April 30, 2026, but below USD 205.0 million one year earlier. That pattern points to improving sequential visibility while project awards and releases remain uneven.

International operations provided support

Kewaunee's international segment generated USD 15.452 million in sales in fiscal Q1 2027, down 7.8 percent year over year. Segment net earnings nevertheless rose 23.5 percent to USD 794,000, while segment EBITDA increased 13.9 percent to USD 1.202 million, supported by a more favorable mix of higher-margin projects, according to PR Newswire.

The company also reported that long-term debt excluding its sale-leaseback financing obligation fell to USD 13.8 million on July 31, 2026, from USD 15.1 million on April 30, 2026. Management said quoting activity remained strong, while broader geopolitical and economic uncertainty extended project award and release timelines.

Stock remains above yearly low

At USD 34.16, Kewaunee Scientific stock was 6.75 percent above its 52-week low of USD 32.00 on October 2, 2026. The same session showed a high of USD 34.61, with volume of 948 shares and market capitalization of USD 99.1 million.

MarketBeat lists a Hold consensus based on one research report. Its rating context places the recent results against a thin coverage base, making backlog conversion and international profitability important indicators for the next reporting cycle.